BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2002
View Archived Issues
First antagonists to demonstrate potency and selectivity for alpha4beta7 compared to other integrins
Read More
Intraperitoneal injection of PYY3-36 inhibits food intake, reduces weight gain in rats and mice
Read More
WR-279396 accelerates cure time of cutaneous leishmaniasis
Read More
New inhibitors of memapsin 2 with potential in Alzheimer's disease
Read More
New safety data approved for Malarone
Read More
BattellePharma and Pharmacia to develop inhalable treatment
Read More
Pirfenidone attenuates neointima development after angioplasty in rats
Read More
Maxim commences clinical study of MX-8899 for the treatment of oral mucositis
Read More
Neulasta approved in E.U.
Read More
Phase IIa trial commences with bimosiamose as treatment for asthma
Read More
Synthesis and SAR studies of selective COX-2 inhibitors disclosed by Pacific Corporation
Read More
Genz-34940 delays induction of acute EAE in mice
Read More
GW-500580X normalizes glucose and insulin levels in obese mice
Read More
Fuzeon early access program opens in the U.S.
Read More
Trisenox rolling out across Europe for treatment of APL
Read More
GlaxoSmithKline submits NDA for once-daily bupropion hydrochloride
Read More
New low-dose strength of Vivelle-Dot launched for prevention of menopausal osteoporosis
Read More
Approvable letter for Genelabs Technologies' Prestara, formerly Aslera
Read More
Aventis declines option to develop pagoclone
Read More
Hepsera chosen as U.S. trade name for adefovir dipivoxil
Read More
New phase I/II trial to evaluate Onco TCS in acute lymphoblastic leukemia
Read More
Selective PPARgamma agonists with utility in the treatment of diabetes
Read More
Roche claims alpha1A and alpha1B adrenergic receptor antagonists
Read More
Sodium channel modulators claimed for pain and migraine
Read More
More telomerase inhibitors disclosed by Geron and Kyowa Hakko
Read More
Estrogen receptor ligands jointly claimed by Karo Bio and Merck & Co.
Read More